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Abstract
Mitochondria play a critical role in cell survival and death after cerebral ischemia. Uncoupling proteins (UCPs) are inner
mitochondrial membrane proteins that disperse the mitochondrial proton gradient by translocating H
+ across the inner
membrane in order to stabilize the inner mitochondrial membrane potential (DYm) and reduce the formation of reactive
oxygen species. Previous studies have demonstrated that mice transgenically overexpressing UCP2 (UCP2 Tg) in the brain
are protected from cerebral ischemia, traumatic brain injury and epileptic challenges. This study seeks to clarify the
mechanisms responsible for neuroprotection after transient focal ischemia. Our hypothesis is that UCP2 is neuroprotective
by suppressing innate inflammation and regulating cell cycle mediators. PCR gene arrays and protein arrays were used to
determine mechanisms of damage and protection after transient focal ischemia. Our results showed that ischemia increased
the expression of inflammatory genes and suppressed the expression of anti-apoptotic and cell cycle genes. Overexpression
of UCP2 blunted the ischemia-induced increase in IL-6 and decrease in Bcl2. Further, UCP2 increased the expression of cell
cycle genes and protein levels of phospho-AKT, PKC and MEK after ischemia. It is concluded that the neuroprotective effects
of UCP2 against ischemic brain injury are associated with inhibition of pro-inflammatory cytokines and activation of cell
survival factors.
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Introduction
Hyperpolarization of the mitochondrial membrane potential
precedes reactive oxygen species production and cell death in
cultured neurons and astrocytes exposed to oxygen and/or glucose
deprivation [1,2]. Inhibiting hyperpolarization protected neuronal
cells from oxidative stress-induced cell death [3]. It is likely that
mitochondrial hyperpolarization places pressure on the electron
transport chain increasing the chance for incomplete oxygen
reduction when there is a persistent flow of electrons from NADH
and FADH2. This condition occurs after recirculation or re-
oxygenation following stroke in vivo or hypoxia in vitro.
Uncoupling proteins (UCPs) are located in the inner mitochon-
drial membrane and function to transport protons into the
mitochondrial matrix. UCPs were first described for the ability to
generate heat without shivering in brown adipose tissue (BAT) [4].
Subsequent studies revealed that reduction of the proton motor
force across the mitochondrial inner membrane by UCP2
decreased the formation of reactive oxygen species [5]. A small
reduction in the mitochondrial membrane potential induced by
mild uncoupling has a significant effect in attenuating reactive
oxygen species (ROS) production [6]. UCP2 is ubiquitously
expressed in all tissues with more levels in the brain and skeletal
muscle at levels up to 1000 times less than UCP1 in BAT [7,8].
Proposed functions of UCP2 include preventing the formation of
ROS and atherosclerosis, participation in inflammation, body
weight regulation, adaptive thermogenesis and aging [9].
The majority of studies have demonstrated increasing UCP2 is
neuroprotective; however, it is still a matter of debate. Up-
regulation of UCP2 has been reported to reduce neuronal damage
in cerebral stroke, traumatic brain injury, epilepsy and Parkinson’s
models [10–13]. Neuroprotective ischemic pre-conditioning and
ischemic post-conditioning up-regulate UCP2 expression [14].
Neuroprotection by ischemic post-conditioning is partially depen-
dent on AKT phosphorylation and involves the mitogen-activated
protein kinase (MAPK) and protein kinase-C (PKC) pathways
[15]. Neuroprotection by ischemic pre-conditioning and hypo-
thermia is dependent on phosphorylated AKT [16,17]. The role of
ERK1/2 in the MAPK pathway during cerebral ischemia is in
debate; however, ERK1/2 is transiently increased in response to
neuroprotective estrogen, hypothermia, ischemic pre-conditioning
and post-conditioning [18,19]. Ischemic pre-conditioning and
post-conditioning prevent the decrease in phosphorylated ePKC
after stroke [15].
Oxidative stress and delayed inflammation are critical factors in
facilitating neuronal death after cerebral ischemia-reperfusion
injury [20]. It has been established that ROS production is
increased after cerebral ischemia and reperfusion and such
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These, in turn, stimulate innate inflammation to generate more
ROS, creating a positive feedback mechanism. Tumor necrosis
factor-a (TNF-a) and interleukin-6 (IL-6) are up-regulated after
ischemic injury [22]. TNF-a has a divergent role in brain injury.
Blocking TNF-a by antibodies, TNF binding protein or genetic
knockout protects against cerebral ischemia [22,23]. In contrast to
those findings, administering TNF-a before cerebral ischemia is
neuroprotective, and ischemic pre-conditioning increases levels of
TNF-a to activate the neuroprotective functions behind Nf-kB
[22,23].
The goals of this study were to explore the mechanisms behind
UCP2-mediated neuroprotection after transient focal ischemia.
We evaluated changes in gene and protein expression related to
inflammation and p53 associated proteins. One hour of middle
cerebral arterial occlusion with 24 hours of reperfusion was
utilized to determine infarct volumes, changes in gene expression
and changes in protein expression. Our results confirmed previous
studies that demonstrated up-regulating UCP2 reduces infarction
after transient focal ischemia [12]. Overexpressing UCP2 reduces
the levels of IL-6 mRNA, but not Tnf-a after ischemia. UCP2 Tg
mice had increased protein levels of phospho-Ser AKT 473, Heat
Shock Protein 90, Protein Kinase C, MAP Kinase Kinase, and




Fifty-seven mice (30 wild-type and 27 UCP2 Tg) were randomly
assigned into control and ischemic group for cerebral vasculature
examination, infarct volume measurement, PCR array and protein
array studies. Number of animals used in each experiment is given
in figure legend. Allprocedures wereperformed instrict compliance
with the National Institutes of Health guidelines for animal research
and were approved by the Institutional Animal Care and Use
Committee. UCP2/3 transgenic overexpressing mice were gener-
ated by overexpressing human UCP2 and UCP3 within the native
promoter [24]. Uncoupling proteins 2, 4 and 5 are the predominant
endogenous isoforms found in brain the brain [8]. Because the
current experiments were performed in brain tissue and UCP3 is
not expressed in brain,, this mouse genotype will be referred to as
UCP2 Tg. Mice were backcrossed onto a C57/Bl6 background.
Micewerefasted overnight with freeaccesstowater. Anesthesia was
induced with 3% and maintained at 1–1.5% isoflurane in 30%
oxygen and 70% nitrous oxide. Body and head temperatures were
maintained between 36.5–37.5uC by a combination of a heating
blanket and a lamp. Animals with a fasting blood glucose level
between4–6 mMwereused for the experiment.Pre-ischemic blood
pressure was 100–120 mmHg with no statistical difference between
UCP2 Tg and wild-type animals.
Anatomy of the Middle Cerebral Artery and Circle of
Willis
Naı ¨ve wild-type and UCP2 Tg mice (n=3 in each group) were
deeply anesthetized and transcardially perfused with 2% India ink
in 20% gelatin in saline. Mice were decapitated after 30 seconds
and brains were removed and fixed with 4% paraformaldehyde.
Brain images were captured using a Leica dissecting scope (Leica
Microsystems, Wetzlar, Germany).
Ischemic model
Transient middle cerebral artery occlusion (MCAO) was
induced in 9 wild-type and 7 UCP2 Tg mice as described before
[25]. Briefly, a nylon monofilament (Doccol, Redlands, CA, USA)
coated with silicon, size 6-0, was inserted into the common carotid
artery to the internal carotid artery in order to block the middle
cerebral artery. Mice were revived and behavior was observed for
neurological defect to confirm the successfulness of MCAO. The
degree of functional deficit at 30 min post occlusion was scored
using a 5-point Bederson’s scale [26]. Briefly, scale 0, no deficit; 1,
mild forelimb weakness; 2, severe forelimb weakness and
consistently turns to side of deficit when lifted by tail;3, compulsory
circling; 4, unconscious; and 5, dead. Three wild-type and 2 UCP2
Tg mice with a Bederson’s score less than 2 were excluded from
the study. After 1 hour of ischemia, mice were re-anesthetized and
the filament was removed to restore blood flow.
Measuring Brain Infarction
Infarct volume was determined by using 2% 2, 3, 5-
Triphenyltetrazolium chloride (TTC) staining. After 1 hour of
MCAO and 24 hours of reperfusion, mice were deeply anesthe-
tized with 5% isoflurane and transcardially perfused with ice cold
saline. The brains were removed and sectioned coronally at 1 mm
thick using a brain matrix (Harvard Apparatus, Holliston, MA,
USA), and incubated in 2% TTC for 15 minutes at room
temperature. Brain slices were then fixed in 4% paraformalde-
hyde, scanned (Hewlett Packard, Palo Alto, CA, USA) into a
computer, and quantified using NIH imaging software (rsb.info.
nih.gov/nih-image).
PCR Array
At 24 hours reperfusion, both control and ischemic animals
from wild-type and UCP2 Tg (n=4 in each group) were
decapitated after being deeply anesthetized with 5% isoflurane.
The brains were extracted within 30 seconds, frozen in liquid
nitrogen and stored at 280uC for later dissection. A peripheral
area of the ipsilateral cortex (equivalent to the ischemic penumbra
area in this model) was dissected in a 220uC glove box. RNA was
isolated by Mini RNeasy Columns (Qiagen, Rockville, MD, USA),
treated with DNase 1for 30 minutes at 37uC and, then,
deactivated with 25 mM EDTA and incubation at 65uC and
stored at 280uC. cDNA was synthesized using 1 mg of RNA
Superscript III and oligo dT (Invitrogen, Carlsbad, CA, USA).
RNA and primers were annealed at 65uC for 5 min. The
Superscript enzyme was added and incubated for 50 min at
50uC. The reaction was terminated by incubating at 85uC for
5 min and stored at 220uC. Ninety-six-well PCR plates pre-
spotted with oligonucleotides for p53 associated genes (Super-
Array, Frederick, MD, USA) were used with SYBR Green RT-
PCR master mix (Invitrogen) and run on the ABI 9600 (Applied
Biosystems, Foster City, CA, USA). One cDNA prep was used for
each array plate. The sample was denatured and polymerase
enzyme was heat activated for 10 min at 95uC, 40 cycles of 15 sec
95uC and 1 min at 60uC amplified the transcript and data was
collected at each cycle. Crossing threshold (Ct) values were
manually set at 2.0 and were normalized to the housekeeping
genes b-actin and HPRT1. The PCR array included control wells
with no template and wells with no primers.
p53 Protein Array
A separate set of animals was used for the antibody protein
array study. At 24 hours reperfusion, mice were decapitated under
deep anesthesia with 5% isoflurane. The brains were excised (n=4
in each group), frozen in liquid nitrogen and stored at 280uC for
later dissection. A peripheral area of the ipsilateral cortex was
dissected in a 220uC glove box. The brains were homogenized
using a tissue homogenizer (Cole-Palmer, Vernon Hills, IL, USA)
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Louis, MO, USA) containing 1 m M EDTA (Sigma), 5 mM DTT
(Sigma) and protease inhibitors (Thermo Scientific, Rockford, IL,
USA). The homogenates were centrifuged at 750 g for 15 min to
separate the nuclear fraction from the cytosolic and mitochondrial
fractions. The supernatant containing the cytosolic and mitochon-
drial proteins was used for cytokine quantification. Protein was
quantified using the A280 protein quantification program on the
NanoDrop 2000 (Thermo Scientific). 1 mg of total protein (at
1 mg/mL) was directly labeled with Cy5 dye reagent (Sigma) in
100 mM carbonate-bicarbonate buffer pH 9.6, excess dye was
removed by a SigmaSpin column, incubated on the protein array
slide (Sigma), and signal was detected using a fluorescent array
reader (Agilent, Santa Clara, CA, USA). Protein levels were
normalized to cytoketerin on the array.
Data analysis
Experiments were carried out by BH and data were analyzed by
PAL without knowing the experimental conditions. T-test was
used to analyze infarct volume between the two species of animals.
PCR data were analyzed using analysis RT
2 Profiler
TM PCR
Array Data Analysis Excel Template provided by SuperArray and
protein array data were analyzed using Data Analysis Workbook
for the Panorama p53 Array provided by Sigma. P value,0.05
was considered statistically significant.
Results
Cerebral Vasculature
To evaluate if transgenically overexpressing UCP2 in the brain
caused a phenotypic change in the cerebral vasculature, we
transcardially injected carbon black ink and imaged the cerebral
blood vessels (Fig. 1). Both wild-type and UCP2 Tg mice
demonstrated intact and correct alignment of the Circle of Willis,
anterior cerebral arteries, middle cerebral arteries and posterior
arteries with no remarkable difference.
Infarct volume
One hour middle cerebral arterial occlusion with 24 hours
reperfusion induced a mild brain damage located predominantly
in the caudate-putamen in wild-type mice. Infarct volume was
measured as a percentage per hemisphere. Mice overexpressing
UCP2 in the brain had significantly less damage after transient
focal ischemia (Fig. 2). Thus the infarct volume was reduced from
18% in wild-type to 12% in UCP2 Tg mice (33% reduction,
p,0.01).
Alteration of Gene Expression
To determine the mRNA expression profile in the ischemic
penumbra area of wild-type and UCP2 Tg mice after transient
focal ischemia, the p53 PCR array (Qiagen, Frederick, MD) was
used to measure transcript levels of 84 genes using quantitative
PCR (ABI 7300). Housekeeping genes Hprt1 and b-actin were
used to normalize results. The original comparisons were made by
comparing wild-type MCAO over wild-type sham, UCP2 Tg
MCAO over UCP2 Tg sham, and UCP2 Tg sham over wild-type
sham. Because of no significant change in gene expression between
UCP2Tg sham and wild-type sham and variation in the UCP2Tg
sham, we decided to use wild-type sham as controls. Data are
summarized in Table 1. After transient focal ischemia in wild-type
mice compared with wild-type sham controls,, cytokines IL-6
(23.36 fold, p=0.05) and Tnf-a (20.19 fold, p,0.001) are
increased significantly. Cell cycle genes: Chek1 (1.78, p=0.024),
Esr1 (3.35 fold, p=0.022), Myc (3.93 fold, p=0.039), and RelA
(1.77 fold, p=0.046), were also increased less profoundly. The
anti-apoptotic gene Bcl-2 (21.98 fold p=0.021) was decreased in
the wild-type ischemic penumbra compared with sham controls.
Cell cycle genes Cdk4 (25.00 fold, p=0.18), Cnng2 (21.76 fold,
p=0.014) and Ccnh (21.42, p=0.074) were also decreased in the
wild-type ischemic penumbra. In UCP2 Tg mice, the cytokines
IL-6 (7.34 fold, p=0.037) and Tnf-a (24.04 fold, p=0.001) were
increased after MCAO compared to wildtype sham controls, but
the increase in IL-6 was much less profound than in wild-type
animals (7.3-fold versus 23.4-fold). Chek1 (2.24 fold, p=0.008),
Esr1 (1.39 fold, p=0.64), Myc (4.28 fold, p=0.0001), and RelA
(1.48 fold, p=0.019) were increased in UCP2 Tg mice after
MCAO. There was no significant decrease in the anti-apoptotic
gene Bcl2 (p=0.226) after MCAO in UCP2 Tg mice. The cell
cycle genes Ccng2 (21.44 fold, p=0.092) and Ccnh (21.40 fold,
p=0.028) were all decreased after MCAO in UCP2 Tg mice. In
summary, ischemia in wild-type mice increased the expression of
inflammatory genes and suppressed the expression of anti-
apoptotic and a few cell cycle genes. Overexpression of UCP2
ameliorated the increase in IL-6, the decrease in Bcl2, and
increased the expression of cell cycle genes as well.
2.4 Change in Cell Signaling Proteins
A protein array focused on p53 associated proteins was used to
measure the change in protein levels in the ischemic penumbra
between UCP2 Tg and wild-type mice after 1 hour MCAO and
24 hours of reperfusion. Protein levels were normalized to pan-
cytokeratin before a comparison was made between the two
groups (Table 2). In comparing UCP2 Tg to wild-type after
MCAO, cell survival related proteins HSP-90, MEK, phospho-
serine 473 AKT, protein p300/CBP, p300/CBP associated
protein and protein kinase C were significantly increased.
Cdc25A, which is a phosphotase mediating c-myc induced
apoptosis, was decreased in UCP2 Tg mice. In addition,
Figure 1. Major cerebral vasculature detected by perfusion of
carbon black in wild-type and UCP2 Tg mice. The Circle of Willis,
anterior cerebral arteries, middle cerebral arteries and posterior arteries
all appear normal in both wild-type and UCP2 Tg animals (n=3 for each
group).
doi:10.1371/journal.pone.0031739.g001
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decreased non-cleaved caspase 9 levels.
Discussion
In this study, we first confirmed that overexpression of UCP2 is
neuroprotective against transient focal ischemia induced brain
damage, which is consistent to previous publication [12]. This
protection was independent from any abnormalities in the cerebral
vasculature. We then investigated the potential mechanisms of
UCP2 mediated neuroprotection.
Decreases in inflammatory cytokines appear to contribute to the
neuroprotection provided by UCP2. Transient focal ischemia
caused 23 and 20 fold increases in IL-6 and Tnf-a mRNA
respectively, suggesting that ischemia induces neuroinflammatory
responses in the brain. Overexpression of UCP2 significantly
reduced the IL-6 expression to less than one third of the levels
observed in wild-type animals after being challenged with
ischemia, suggesting that UCP2 suppresses neuroinflammation in
the brain after stroke. Reports have shown that expression of IL-6
in human patients after ischemic stroke is associated with the size
of infarction [27]. IL-6 is increased in brain injury and is directly
up-regulated by IL-1b and TNF-a [28].Mice transgenically
overexpressing the antioxidant enzyme glutathione peroxidase
had reduced expression of IL-6 after transient focal ischemia [29].
It is possible that suppression of IL-6 lessens inflammatory
response. This is supported by studies showing that UCP2/3
overexpressing mice have reduced inflammatory responses after
endotoxin challenges and decreased IL-6 and IL-4 levels after
lipopolysaccharide challenge [24] and that UCP2 homozygous
knockout (UCP2
2/2) mice have increased expression of IL-6 after
listeria infection compared with wild-type controls [30].
Ischemia in wild-type mice suppressed Bcl2 and overexpression
of UCP2 alleviated the suppression. Bcl2 is a well-known anti-
Figure 2. Infarct volume at 24 hours of recovery after 1 hour MCAO. A, Representative TTC stained brain sections depict the infarct area
(white color). B, percentage of infarct volume per hemisphere. Data were collected from 6 wild-type and 5 UCP2 Tg mice. * P,0.05, Student t test.
doi:10.1371/journal.pone.0031739.g002






WT MCAO/WT sham P value TG MCAO/Sham p value
Bcl2 B-cell leukemia/lymphoma 2 21.98 0.021 21.43 0.226
Ccng2 Cyclin G2 21.17 0.031 21.44 0.092
Ccnh Cyclin H 21.42 0.074 21.40 0.028
Chek1 Checkpoint kinase 1 homolog 1.78 0.024 2.24 0.008
Esr1 Estrogen receptor 1 alpha 3.35 0.022 1.39 0.639
Il6 Interleukin 6 23.36 0.050 7.34 0.037
Mcl1 Myeloid cell leukemia sequence 1 22.24 0.362 4.52 0.152
Myc Myelocytomatosis oncogene 3.93 0.039 4.28 ,0.001
RelA V-rel reticuloendothe-liosis viral oncogene homolog A 1.77 0.046 1.48 0.019
Tnf Tumor necrosis factor 20.19 ,0.001 24.04 0.001
After being normalized against house-keeping gene, the average delta Ct values of targets genes were compared between the test samples and control samples (n=4
in each group) and presented as fold change. Negative value indicates decrease and positive value indicates increase compared to control. Data were analyzed using
RT
2 Profiler
TM PCR Array Data Analysis Excel Template provided by SuperArray.
doi:10.1371/journal.pone.0031739.t001
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pathway. Bcl-2 provides protection from oxidative stress [31] and
cerebral ischemia [32]. Transgenically overexpressing Bcl-2
reduced infarction from permanent focal ischemia [33]. Upregula-
tion of Bcl-2 is associated with several neuroprotective strategies
including ischemic pre-conditioning [34]. Our studies confirmed
previous findings that cerebral ischemia reduces the transcript
levels of Bcl-2 [35] and showed that upregulation of UCP2 in
transgenic mice ameliorated ischemia-induced Bcl2 suppression.
Similarly, Mcl-1, a Bcl-2 family protein [36,37]. is suppressed by
ischemia and its suppression is elevated by UCP2 overexpression.
These data suggest that the neuroprotective effects of UCP2 may
be associated with prevention of Bcl2 family suppression induced
by cerebral ischemia. This is supported by the study showing that
upregulation of UCP2 by ghrelin protects hypoxia-induced
damage by increasing Bcl-2/Bax ratios [38].
Ischemia resulted in cell arrest as reflected by the suppression of
cell cycle genes cyclin G2 and cyclin H,, which stimulate cell
proliferation and survival [39,40]. UCP2 overexpression alleviated
ischemia-induced suppression on cyclin G2 and cyclin H,
suggesting that the neuroprotective effects of UCP2 may be
associated with cell cycle regulation.
Estrogen receptor alpha (Esr1) and checkpoint kinase 1 (Check1)
are involved in neuroprotection, DNA repair and regulation of cell
proliferation [40,41]. In the present study, Esr1 increased after
ischemia and reperfusion injury, suggesting ischemia activates cell
protective machinery. However, since UCP2 did not increase Esr1,
its neuroprotetive effects may not be associated with Esr1. Two
oncogenes, Myc and RelA, are upregluated by ischemia. This is
consistent with previous publication showing increased Myc in
brain after cerebral ischemia [42]. While the role of these two genes
in ischemic brain damage has not been established, persistent
expression of Myc induces apoptosis [43]. RelA is a major
component of NF-kB transcription factor [44]. Since Myc and
RelA are both upregluated after focal ischemia in both wild-type
and UCP2 Tg mice, UCP2 mediated neuroprotection may not be
associated with these two genes.
UCP2 activates cell survival signaling pathways. The protein
levels of HSP90, phospho-AKT, PKC, p300/CBP, p300/CBP
associated factor (PCAF), and MEK were significantly increased in
the ischemic penumbra of UCP2 Tg mice after transient focal
ischemia compared to wild-type ischemic mice. Ischemic precon-
ditioning is known to increase HSP90 [45]. Inhibiting HSP90 with
geldanamycin increased oxidative stress and cell death in PC12
cells [46]. Neuroprotective hypothermia, ischemic pre-condition-
ing and ischemic post-conditioning cause phosphorylation of AKT
473 [17,18] and PKC [47]. Inhibiting phosphorylation of AKT
blocks the beneficial effects of hypothermia, ischemic pre- and
post-conditioning [17,18]. Upregulating UCP2 by ghrelin provides
neuroprotection by activating ERK and PKC pathways [38].
MEK phosphorylates MAP kinase (ERK) and promotes cell
proliferation. MEK protects from glutamate-induced damage in
neuronal cultures [19]. Inhibiting MEK blocked neuroprotection
by ischemic pre-conditioning [18]. p300/CBP plays a critical role
in transcriptional regulation of hypoxia responsive genes, including
hypoxia-inducing factor and its downstream vascular endothelial
growth factor (VEGF) and erythropoietin [48]. Both VEGF and
erythropoietin protect brain against ischemic injury [49,50]. Our
results suggest that UCP2 protects against ischemia-induced brain
damage by activating cell survival signals.
UCP2 decreases protein levels of Cdc25A in the ischemic
penumbra region. Cdc25A is a phosphatase with significant roles
in cell cycle progression by activating cyclin dependent kinases
[51]. It is regulated post-translational by the ubiquitin-proteasome
pathway [52]. Cdc25A is necessary for c-myc induced apoptosis.
Cdc25a activity is increased in degenerating neurons of patients
who died with Alzheimer’s disease [51]. Blocking Cdc25a inhibits
c-myc mediated apoptosis [53]. UCP2 decreases the levels of
Cdc25a, therefore it may reduce apoptotic cell death induced by
ischemia.
The protein levels of caspase-3 increased and caspase-9
decreased in the ischemic penumbra of UCP2 Tg mice. Since
the measured caspase-3 and caspase-9 are the uncleaved form, it is
not clear whether the increase in caspase3 or decrease in capspase-
9 has any pathogenic meaning.
Our results confirmed overexpressing UCP2 is neuroprotective
from transient focal ischemia. Overexpressing UCP2 suppresses
mRNA levels of inflammatory cytokine and elevated the ischemia-
induced suppression of cell cycle genes. Furthermore, overexpres-
sion of UCP2 increases the protein levels of cell survival factors.
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